Analysts are bullish on these following companies: Medlab Clinical, Nearmap, Animoca Brands. These companies are relatively strong financially, and have a great outlook in terms of profits and cash flow. I would suggest taking a look at my list of companies that compare favourably in all criteria, and consider whether they would add value to your current portfolio.
Nearmap Ltd provides online aerial photomapping services in Australia and the United States. Nearmap was formed in 2000 and has a market cap of AUD $235.02M, putting it in the small-cap stocks category.
NEA is expected to deliver an impressive top-line growth of 67.77% over the next couple of years, according to market analysts. Furthermore, the 199.56% growth in operating cash flows indicates that a large portion of this revenue increase is high-quality, day-to-day cash generated by the business, rather than one-offs. The market’s bullish sentiment on NEA’s capacity to grow at such high rates makes it an interesting stock to dig into deeper. Could this stock be your next pick? Have a browse through its key fundamentals here.
ASX:NEA Future Profit Oct 6th 2017
